Alvogen And Pfenex Have Teriparatide Filing Accepted By EMA

 
• By Aidan Fry

The EMA has formally accepted for filing Alvogen and Pfenex’ centralized marketing authorization application for a biosimilar rival to Lilly’s Forsteo teriparatide blockbuster.  

Acceptance
Alvogen and Pfenex have had their teriparatide biosimilar accepted for filing by the EMA • Source: Shutterstock

More from Biosimilars

More from Products